Life Sciences Angel Pitch

Sponsored by: Morgan Lewis & Bockius LLP

8/31/2016 • 6:30 - 8:30 PM

Morgan Lewis & Bockius LLP
1400 Page Mill Road
Palo Alto, CA 94304-1124

This event has concluded. The content below is provided for informational purposes only.


John Butler, CEO, Quantumcyte


Gary Zweiger, Co-founder and Managing Director, BioInfleXion Point Partners

Mira Chaurushiya, PhD, 5am Ventures

Norm Gitis, Life Science Angels

Ben Pensak, Morgan Lewis

Faz Bashi, Angel Capital Association

The Life Science Investor Pitch programs through VC Taskforce offer an opportunity for entrepreneurs seeking startup funding to pitch in front of a distinguished panel of investors. VC Taskforce and Morgan, Lewis & Bockius, LLP have partnered to bring to you a scintillating program series to bring entrepreneurs and investors together in the life science fields. The evening will be exciting and a terrific learning experience for all entrepreneurs. Entrepreneurs learn what investors are looking for in a pitch presentation.

Entrepreneurs seeking capital will pitch for 2 minutes in front of the investor panel. This is followed by 5 minutes of Q&A and then non-rebuttal feedback by the panel. A score of 1-5 is given to each presenting company by each panel member. Please note that pitching time limits will be strictly enforced!

Investors come and listen to entrepreneurs’ pitches. You never know where you’ll find your next deal. Find out how our panel of investors rates entrepreneurs’ pitches; which investors pass and for what reasons; and which entrepreneurs other investors want to talk to ASAP. Please let us know if you would like to participate on one of our Life Science Investor Pitch panels.

This is a great opportunity for entrepreneurs to network with investors, present their company, and hear first-hand what it takes to raise early-stage capital. If you are an entrepreneur in a startup that is currently seeking capital and would like to present your best 2 minute elevator pitch to a panel of investors, you must register in advance and have confirmation from the program manager that you are on the list of presenters. The maximum number of presenters is limited to ten.

Moderator: John Butler, CEO, Quantumcyte

Norm Gitis, Managing Partner, Lymo Ventures. Medtech Committee Chair and Board member, Life Science Angels. Life Science Chair of the Screening Committee, Band of Angels.
Gary Zweiger, Co-founder and Managing Director of BioInfleXion Point Partners
Mira Chaurushiya, PhD. Associate, 5AM Ventures. Focuses on early stage therapeutics investments, as well as research tools and technologies.
Faz K. Bashi, MD, Angel Capital Association, Member, Board of Directors: Chair of Life Science Syndication and Chair, Collaboration Committee.
Ben Pensak, Morgan Lewis

To present a pitch, prior to registering, please contact Mark Atlas or call 408.857.9004 to learn of slot availability. Slots to present are assigned on a first-come basis. If a slot is available you must register and send Mark Atlas your confirmation number and the name of your company. Receipt of your confirmation number ensures assignment of a presentation slot. You will also receive further instructions and advice on preparing your best pitch.

Please note: You must contact Mark Atlas per instructions above to reserve a slot to pitch. You will then be sent a link to register.

Doors open and networking: 6 PM
Program: 6:30-8:30 PM
Hors d'oeuvres and beverages will be served.

VC Taskforce Members
Affiliate Organization Members
General Admission
(If space is available, door registration is an additional $10)

If you would like to be attend to watch (but not pitch), please use this link:

Registration for general attendance.


Program Registrar: Mark Atlas 408.857.9004

Life Science Co-Chairs: Mark Atlas and John Butler

For More Information

For event information on this or any other event, tickets, membership information or more, contact June Riley at VC Taskforce.


VC Taskforce™ has built an organization that the venture community can give input and direction to and get immediate results that benefit both investors and their portfolio companies.

Contact Us

For additional information, please get in touch:

June Riley
CEO, VC Taskforce